Type
Internal restructuring
Country
Belgium
Region
Vlaams Gewest; Prov. Antwerpen; Arr. Antwerpen
Location of affected unit(s)
Puurs
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations

250 jobs
Number of planned job losses
Job loss
Announcement Date
1 October 2024
Employment effect (start)
31 October 2024
Foreseen end date

Description

Pfizer a US-based multinational pharmaceutical producer has announced it will reduce its workforce by 250 employees at its facility in Puurs. The main reasoning behind the restructuring is a worldwide cost-reducing effort, this effort was initiated after the increase in demand for vaccinations died down post-Covid-19 pandemic.

The facility in Puurs was one of the major facilities that produced COVID-19 vaccinations, hence it is the target of austerity. The company management stated that no personnel would be dismissed, instead 250 employees leaving the company will not be replaced. Trade unions at the facility are not planning any actions but are critical of the reasoning behind the measure.


Sources

Citation

Eurofound (2024), Pfizer, Internal restructuring in Belgium, factsheet number 202275, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/202275.